Wegovy Side Effects: What to Expect and How to Manage Them

Wegovy® (semaglutide 2.4 mg) is an FDA-approved injectable medication for chronic weight management. As a GLP-1 receptor agonist, it works by mimicking a natural hormone that regulates appetite, food intake, and blood sugar levels. While clinical trials like the STEP program have demonstrated meaningful weight loss results, understanding potential side effects is essential for anyone considering or currently using this medication.

This guide covers the most commonly reported Wegovy side effects, how to manage them, and when to seek medical attention — so you can make informed decisions about your treatment.

How Wegovy Works

Wegovy contains semaglutide, a synthetic version of the GLP-1 hormone naturally produced in your gut. When injected weekly, it activates GLP-1 receptors in the brain that help regulate appetite and satiety signals. The medication slows gastric emptying — meaning food stays in your stomach longer — which may contribute to reduced hunger and calorie intake.

Wegovy is prescribed at gradually increasing doses over 16–20 weeks to help minimize side effects. This dose-escalation schedule is a key strategy for tolerability, starting at 0.25 mg weekly and building up to the maintenance dose of 2.4 mg.

Common Wegovy Side Effects

Clinical trials from the STEP program reported that gastrointestinal side effects were the most frequently observed. Most of these tend to be mild to moderate and often improve as the body adjusts to the medication.

Gastrointestinal Effects

• Nausea: The most commonly reported side effect, affecting a significant proportion of participants in clinical trials. Nausea tends to peak during dose escalation and often diminishes over time.
• Diarrhea: Some patients experience loose stools, particularly in the early weeks of treatment or after dose increases.
• Constipation: Slowed gastric emptying can contribute to constipation in some individuals.
• Vomiting: Less common than nausea but reported in clinical trials, especially during dose adjustments.
• Abdominal pain: Mild stomach discomfort or cramping may occur, usually resolving within a few weeks.

Other Common Side Effects

• Headache: Reported by some patients, particularly early in treatment.
• Fatigue: Some individuals notice tiredness or low energy levels during the initial weeks.
• Dizziness: Occasional lightheadedness, which may relate to changes in blood sugar or reduced caloric intake.
• Injection site reactions: Mild redness, swelling, or itching at the injection site are possible but typically resolve quickly.

Serious Side Effects to Watch For

While most Wegovy side effects are mild, there are some serious adverse events that require prompt medical attention. These are uncommon but important to be aware of:

Pancreatitis

Inflammation of the pancreas has been reported in some patients using GLP-1 receptor agonists. Symptoms include severe, persistent abdominal pain that may radiate to the back, often accompanied by nausea and vomiting. If you experience these symptoms, stop the medication and contact your provider immediately.

Gallbladder Problems

Rapid weight loss — regardless of the method — can increase the risk of gallstones. Studies suggest that GLP-1 medications may further contribute to this risk. Symptoms of gallbladder issues include severe upper abdominal pain, fever, and jaundice (yellowing of the skin or eyes).

Kidney Problems

Dehydration from persistent nausea, vomiting, or diarrhea can potentially affect kidney function. Staying well-hydrated is important, especially during periods of GI distress. Report any significant decrease in urination or swelling to your provider.

Thyroid Concerns

Semaglutide carries a boxed warning about thyroid C-cell tumors observed in rodent studies. While this risk has not been confirmed in humans, Wegovy is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Report any lump or swelling in the neck, hoarseness, or difficulty swallowing to your provider.

Hypoglycemia

Low blood sugar is more of a concern when Wegovy is combined with other diabetes medications like insulin or sulfonylureas. Symptoms include shakiness, sweating, rapid heartbeat, and confusion. If you take diabetes medications, your provider may need to adjust doses.

How to Manage Wegovy Side Effects

Many side effects can be minimized with proactive strategies. Here are evidence-based approaches that may help:

Managing Nausea

• Eat smaller, more frequent meals: Large meals can worsen nausea. Try eating 4–6 smaller portions throughout the day.
• Avoid fatty or greasy foods: High-fat meals can exacerbate GI symptoms when combined with slowed gastric emptying.
• Stay hydrated: Sip water throughout the day rather than drinking large amounts at once.
• Eat bland foods when symptomatic: Crackers, toast, rice, and bananas are generally well-tolerated during nausea episodes.
• Time your injection wisely: Some patients find that injecting in the evening allows them to sleep through the initial nausea window.

Managing Constipation

• Increase fiber intake gradually: Fruits, vegetables, and whole grains can help promote regularity.
• Drink plenty of water: Adequate hydration is crucial for healthy digestion.
• Stay physically active: Regular movement supports digestive function.
• Talk to your provider about stool softeners: Over-the-counter options may be appropriate if dietary changes alone don't help.

Managing Fatigue

• Ensure adequate protein intake: Reduced appetite can lead to insufficient nutrition. Focus on protein-rich foods to maintain energy.
• Maintain regular sleep habits: Consistent sleep and wake times support overall energy levels.
• Moderate exercise: Light to moderate physical activity may actually help combat fatigue.

When Do Side Effects Typically Resolve?

Research from the STEP trials suggests that most GI side effects peak during the dose-escalation phase and tend to diminish within 4–8 weeks at each dose level. Many patients report significant improvement by the time they reach the maintenance dose, though individual experiences vary.

If side effects persist or become severe, your provider may slow the dose escalation, temporarily reduce the dose, or explore other management strategies. Open communication with your provider is essential for optimizing your treatment experience.

Who Should Not Take Wegovy?

Wegovy is not appropriate for everyone. It is contraindicated in individuals with:

• A personal or family history of medullary thyroid carcinoma or MEN 2
• Known hypersensitivity to semaglutide or any component of the formulation
• Pregnancy or plans to become pregnant (Wegovy should be discontinued at least 2 months before planned conception)

Additionally, individuals with a history of pancreatitis, gallbladder disease, or severe kidney disease should discuss the risks thoroughly with their provider before starting treatment.

The Bottom Line

Wegovy side effects are a real consideration, but for many patients, they are manageable — especially with the gradual dose-escalation approach and proactive symptom management. The most common side effects are gastrointestinal in nature and tend to improve over time. Serious side effects, while possible, are uncommon.

Working with a licensed provider who can monitor your response, adjust dosing as needed, and address concerns promptly is the best way to ensure a safe and effective treatment experience.

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any treatment.